Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PVAG-14 Pilot in Intermediate Stage Hodgkin's Lymphoma
NCT00512980Phase 2Terminated
- Sponsor
- University of Cologne
- Start
- Aug 2008
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in Hodgkin lymphoma (HL), sponsored by University of Cologne. Started Aug 2008; status: terminated.
02
Drugs
gemcitabine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00512980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512980.